A Prospective, Randomized, Multicenter Comparative Study of Clinafloxacin Versus a Ceftriaxone-based Regimen in the Treatment of Hospitalized Patients with Community-acquired Pneumonia

By Petermann W.   Alegre-Martin J.   Odenholt I.   Phillips M. J.   Willcox P. A.   Tack K.   Trostmann U.   Welling L.  

Scandinavian Journal of Infectious Diseases, Vol. 33, Iss. 11, 2001-11 ,pp. : 832-837

Informa Healthcare

Access to resources Recommend Favorite

Linezolid Versus Ceftriaxone/Cefpodoxime in Patients Hospitalized for the Treatment of Streptococcus pneumoniae Pneumonia

By San Pedro Gerry S.   Cammarata Sue K.   Oliphant Thomas H.   Todisco Tommaso  

Scandinavian Journal of Infectious Diseases, Vol. 34, Iss. 10, 2002-10 ,pp. : 720-728

Informa Healthcare

Access to resources Recommend Favorite

A cost-minimisation analysis comparing moxifloxacin with levofloxacin plus ceftriaxone for the treatment of patients with community-acquired pneumonia in Germany: results from the MOTIV trial

By Lloyd A.   Holman A.   Evers T.  

Current Medical Research and Opinion, Vol. 24, Iss. 5, 2008-05 ,pp. : 1279-1284

Informa Healthcare

Access to resources Recommend Favorite

Medical resource utilization among community-acquired pneumonia patients initially treated with levofloxacin 750 mg daily versus ceftriaxone 1000 mg plus azithromycin 500 mg daily: A US-based study*

By Frei C. R.   Jaso T. C.   Mortensen E. M.   Restrepo M. I.   Raut M. K.   Oramasionwu C. U.   Ruiz A. D.   Makos B. R.   Ruiz J. L.   Attridge R. T.   Mody S. H.   Fisher A.   Schein J. R.  

Current Medical Research and Opinion, Vol. 25, Iss. 4, 2009-04 ,pp. : 859-868

Informa Healthcare

Access to resources Recommend Favorite

Association between pneumococcal pneumonia and venous thromboembolism in hospitalized patients: A nationwide population‐based study

By  

RESPIROLOGY (ELECTRONIC), Vol. 20, Iss. 5, 2015-07 ,pp. : 799-804

John Wiley & Sons Inc

Access to resources Recommend Favorite